Results 131 to 140 of about 24,071 (243)

Efficacy and Safety of Aflibercept Biosimilars Relative to Reference Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis

open access: yesClinical Ophthalmology
Hazem Saleh Aljuhani,1,* Rahaf A Hubayni,2,3,* Jumanah Qedair,2,3 Ziad M Bukhari,4 Ahmed Alzahrani,4 Razan Osama Bawazir,2,3 Orjwan Salah Badghaish,2,3 Faisal Alqahtani5 1Ophthalmology Department, Jeddah Eye Hospital, Jeddah, Saudi Arabia;
Aljuhani HS   +7 more
doaj  

Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration

open access: yesClinical Ophthalmology, 2019
Naoko Koike,1 Tsuyoshi Otsuji,1 Akiko Tsumura,1 Katsuaki Miki,1 Yukio Sakai,1 Tetsuya Nishimura,1 Kanji Takahashi21Department of Ophthalmology, Kansai Medical University Medical Center, Osaka, Japan; 2Department of Ophthalmology, Kansai Medical ...
Koike N   +6 more
doaj  

Folfiri-aflibercept vs folfiri-bevacizumab as second line treatment of RAS mutated metastatic colorectal cancer in real practice

open access: hybrid, 2018
Alessandro Ottaiano   +7 more
openalex   +1 more source

Initiation of intravitreal aflibercept injection treatment in patients with diabetic macular edema: a review of VIVID-DME and VISTA-DME data [PDF]

open access: gold, 2016
Focke Ziemssen   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy